Australia markets closed

Alpha Tau Medical Ltd. (DRTS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.4700+0.0100 (+0.41%)
At close: 04:00PM EDT
2.3800 -0.07 (-2.86%)
After hours: 04:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.4600
Open2.4900
Bid0.0000 x 0
Ask0.0000 x 0
Day's range2.3801 - 2.4900
52-week range2.1500 - 4.8000
Volume6,740
Avg. volume35,340
Market cap172.086M
Beta (5Y monthly)0.76
PE ratio (TTM)N/A
EPS (TTM)-0.4200
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.25
  • GlobeNewswire

    Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow

    - Initial data demonstrates significant reduction in distant pancreatic cancer tumor growth rate starting from three weeks after first tumor is treated with Alpha DaRT alone - Effect seen across both Panc02 and KPC tumor models - JERUSALEM, May 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today the presentation of new preclinical data at the 2024 con

  • GlobeNewswire

    Alpha Tau to Participate in May Investor Conferences

    JERUSALEM, May 01, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present at the following investor conferences in May 2024. Event:Guggenheim Securities Radiopharmaceuticals DayFormat:PresentationDate:May 13, 2024Time:11:30AM ETLocation:New York, NY Event:H.C. Wainwright 2ndAnnual BioConnect Investor ConferenceFormat:Fireside

  • GlobeNewswire

    Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit

    JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Radiopharma Innovation Summit on April 11th, 2024. Event:Jefferies Radiopharma Innovation SummitDate:April 11, 2024Time:12:40-1:10 PM ESTLocation:New York, NY Mr. Levy will also be available for 1x1 inv